GILEAD SCIENCES, INC. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Gilead Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Gilead Sciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $888M, a 66.1% decline year-over-year.
  • Gilead Sciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $822M, a 90% decline year-over-year.
  • Gilead Sciences, Inc. annual Operating Income (Loss) for 2023 was $7.61B, a 3.75% increase from 2022.
  • Gilead Sciences, Inc. annual Operating Income (Loss) for 2022 was $7.33B, a 26.1% decline from 2021.
  • Gilead Sciences, Inc. annual Operating Income (Loss) for 2021 was $9.92B, a 144% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $822M $888M -$1.74B -66.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $2.56B $2.64B +$979M +58.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.58B -$4.32B -$6.03B -353% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $7.61B $1.61B -$655M -28.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $8.26B $2.62B -$214M -7.54% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $8.47B $1.67B -$364M -17.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $8.84B $1.71B +$1.51B +765% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $7.33B $2.27B +$1.33B +141% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $6B $2.84B -$1.01B -26.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $7.01B $2.03B -$217M -9.66% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $7.23B $197M -$2.69B -93.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $9.92B $940M -$1.71B -64.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $11.6B $3.84B +$1.84B +92% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $9.79B $2.25B +$5.23B Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $4.56B $2.89B +$488M +20.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $4.07B $2.65B +$1.56B +143% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $2.51B $2B +$3.47B Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$961M -$2.98B -$5.41B -223% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $4.45B $2.4B +$165M +7.38% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $4.29B $1.09B -$51M -4.46% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $4.34B -$1.47B -$4.1B -156% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $8.43B $2.43B +$150M +6.58% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $8.28B $2.24B +$84M +3.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $8.2B $1.14B -$1.15B -50.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $9.35B $2.62B -$1.19B -31.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $10.5B $2.28B -$1.97B -46.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $12.5B $2.15B -$1.61B -42.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $14.1B $2.29B -$1.75B -43.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $15.9B $3.81B -$587M -13.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $16.5B $4.25B -$284M -6.26% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $16.7B $3.77B -$884M -19% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $17.6B $4.05B -$1.58B -28% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $19.2B $4.4B -$1.19B -21.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $20.4B $4.54B -$1.08B -19.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $21.5B $4.65B -$720M -13.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $22.2B $5.62B +$1.29B +29.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $20.9B $5.59B +$2.11B +60.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $18.8B $5.62B +$1.2B +27.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $17.6B $5.37B +$2.33B +76.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $15.3B $4.33B +$3.13B +262% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $12.1B $3.48B +$2.33B +203% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $9.8B $4.41B +$3.26B +282% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $6.54B $3.04B +$2.02B +197% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $4.52B $1.2B +$90.2M +8.15% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-24
Q3 2013 $4.43B $1.15B +$104M +9.96% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $4.33B $1.15B +$94.7M +8.95% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $4.24B $1.03B +$225M +28.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $4.01B $1.11B +$239M +27.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $3.77B $1.04B +$40.2M +4.01% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 $3.73B $1.06B +$42.4M +4.17% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $3.69B $800M -$102M -11.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $3.79B $867M +$38.1M +4.59% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $3.75B $1B +$24.6M +2.51% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $3.73B $1.02B +$24.1M +2.43% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 $3.7B $902M -$259M -22.3% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $3.96B $829M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $979M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $993M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 $1.16B Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.